[HTML][HTML] Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist
M van Deuren, JJC Kroot, DW Swinkels - haematologica, 2009 - ncbi.nlm.nih.gov
M van Deuren, JJC Kroot, DW Swinkels
haematologica, 2009•ncbi.nlm.nih.govTime-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient
with Schnitzler’s syndrome treated with IL-1 receptor antagonist - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content
Main Navigation Search PMC Full-Text Archive Search in PMC Advanced Search User Guide
Journal List Haematologica v.94(9); 2009 Sep PMC2738724 Other Formats PubReader PDF
(132K) Actions Cite Collections Share Permalink Copy RESOURCES Similar articles Cited …
with Schnitzler’s syndrome treated with IL-1 receptor antagonist - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content
Main Navigation Search PMC Full-Text Archive Search in PMC Advanced Search User Guide
Journal List Haematologica v.94(9); 2009 Sep PMC2738724 Other Formats PubReader PDF
(132K) Actions Cite Collections Share Permalink Copy RESOURCES Similar articles Cited …
IL-6-hepcidin axis in the development of hypoferremia and anemia of inflammation; and ii) suggests that chronic inflammation protects patients with HFE-related hereditary hemochromatosis from iron accumulation.
ncbi.nlm.nih.gov